PETER WILCOX: Open Payments
NPI 1285049965 · SILVERDALE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,506 in 99 payments from 18 companies in 2025. Trend: 2023 $2,800 · 2024 $2,186 · 2025 $5,506
Consulting: $3,000Food & beverage: $1,808Travel & lodging: $656Education: $42
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $3,895 |
| Amgen Inc. | 10 | $197 |
| Lilly USA, LLC | 10 | $168 |
| Amphastar Pharmaceuticals, Inc. | 12 | $168 |
| Tandem Diabetes Care, Inc. | 8 | $132 |
| Xeris Pharmaceuticals, Inc. | 6 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $110 |
| Novo Nordisk Inc | 5 | $109 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| Abbott Laboratories | 4 | $82 |
Products named: CRENESSITY, t:slim X2 Insulin Pump with Control-IQ, JARDIANCE, MOUNJARO, EVENITY, GVOKE HYPOPEN, LEQVIO, FREESTYLE LIBRE 3.
Industry payments across WA — which companies pay providers there.
